Drugs Made In America Acquisition (DMII) Cash from Operations (2025)
Drugs Made In America Acquisition (DMII) posted quarterly Cash from Operations of 314864.0 for Q4 2025.
Drugs Made In America Acquisition (DMII) Cash from Operations (2025) Analysis & Trends
Drugs Made In America Acquisition (DMII) has reported Cash from Operations for 1 consecutive years, with 314864.0 the latest figure, recorded in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oxley Bridge Acquisition | 585.76 Mn | 585.76 Mn | - | -162,173.00 |
| 2 | Launch Two Acquisition | 557.86 Mn | 557.86 Mn | - | -109,362.00 |
| 3 | Drugs Made In America Acquisition | 507.00 Mn | 507.00 Mn | - | - |
| 4 | Cantor Equity Partners IV | 468.00 Mn | 468.00 Mn | - | - |
| 5 | GP-Act III Acquisition | 401.06 Mn | 401.06 Mn | - | - |
| 6 | Aldel Financial | 397.49 Mn | 397.49 Mn | - | 2.14 Mn |
| 7 | Republic Digital Acquisition | 389.25 Mn | 388.51 Mn | - | -58,765.00 |
| 8 | Gores Holdings X | 385.06 Mn | 384.87 Mn | - | -267,322.00 |
| 9 | Agriculture & Natural Solutions Acquisition | 377.29 Mn | 377.04 Mn | - | - |
| 10 | CSLM Digital Asset Acquisition Corp III | 322.52 Mn | 314.90 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -314,864.00 |
| Dec 31, 2025 | -314,864.00 |